ArticleScientific reports2022

Incidence of and risk factors for severe neutropenia during treatment with the modified FOLFIRINOX therapy in patients with advanced pancreatic cancer.

Ai Irisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.